Heparin-associated thrombocytopenia. 1981

J Olin, and R Graor

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias

Related Publications

J Olin, and R Graor
September 1995, The Journal of the Arkansas Medical Society,
J Olin, and R Graor
October 1980, The New England journal of medicine,
J Olin, and R Graor
January 1989, Acta chirurgica Belgica,
J Olin, and R Graor
March 1981, The Journal of the American Osteopathic Association,
J Olin, and R Graor
April 1984, Annals of internal medicine,
J Olin, and R Graor
August 1984, Annals of internal medicine,
J Olin, and R Graor
August 1992, Critical care medicine,
J Olin, and R Graor
May 1986, Anesthesia and analgesia,
J Olin, and R Graor
December 1998, Critical care nurse,
J Olin, and R Graor
November 1983, Annals of internal medicine,
Copied contents to your clipboard!